성장을 멈추지 마세요

체험은 만족하셨나요?

현재 45,766명이 마이메르시로 공부 중이에요

지식 자료를 소장하고 멋진 의료인으로 성장하세요

학습 자료 둘러보기 →
Kidney Tumors | 마이메르시 MyMerci
제안하기

뭔가 하고 싶은 말이 있는거야?

0 / 2000
컨텐츠 수정하기

컨텐츠 내용을 수정할 수 있습니다

수정하기
닫기

Kidney Tumors

NCLEX Review Guide: Kidney Tumors

Pathophysiology and Types

Renal Cell Carcinoma (RCC)

  • Renal cell carcinoma accounts for 85% of all kidney cancers and typically originates in the proximal tubule epithelium. Clear cell carcinoma is the most common subtype, characterized by cells with clear cytoplasm due to glycogen and lipid accumulation.
  • Risk factors include smoking, obesity, hypertension, chronic kidney disease, and genetic conditions like von Hippel-Lindau syndrome. Male gender and advanced age (peak incidence 50-70 years) also increase risk significantly.

Memory Aid: RCC Risk Factors

"SMOKY GENES"
S - Smoking
M - Male gender
O - Obesity
K - Kidney disease (chronic)
Y - Years (advanced age)
G - Genetics (VHL syndrome)
E - Elevated BP (hypertension)
N - Nephrotoxic substances
E - Environmental toxins
S - Sclerosis (tuberous sclerosis)

Key Points

  • Often called "silent tumor" - symptoms appear late in disease progression
  • Classic triad (hematuria, flank pain, palpable mass) occurs in <10% of patients
  • May present with paraneoplastic syndromes (hypercalcemia, polycythemia)

Clinical Manifestations

Early vs. Late Signs and Symptoms

  • Hematuria is the most common presenting symptom, occurring in 40-50% of patients and may be gross or microscopic. Painless hematuria in adults over 40 requires immediate urological evaluation to rule out malignancy.
  • Systemic symptoms include unexplained weight loss, fatigue, fever, and night sweats, often indicating advanced disease. Paraneoplastic syndromes occur in 20% of patients due to hormone-like substances produced by tumor cells.

Clinical Scenario

A 62-year-old male smoker presents with intermittent painless gross hematuria for 2 weeks. He reports 15-pound weight loss over 3 months and persistent fatigue. Physical exam reveals a palpable right flank mass. Lab results show hypercalcemia and elevated ESR.

Priority nursing assessment: Obtain detailed smoking history, assess for additional symptoms of metastasis, and prepare patient for immediate imaging studies.

Early vs. Advanced Disease Comparison

Early Disease Advanced Disease
• Asymptomatic or mild hematuria
• Incidental finding on imaging		 • Classic triad symptoms
• Systemic symptoms
• Paraneoplastic syndromes
• Normal lab values
• Localized on imaging		 • Anemia, hypercalcemia
• Evidence of metastasis

Diagnostic Studies and Staging

Imaging and Laboratory Studies

  • CT scan with contrast is the gold standard for diagnosis and staging, providing detailed information about tumor size, location, and potential metastasis. Triple-phase CT includes pre-contrast, arterial, and venous phases to characterize renal masses.
  • Laboratory studies include CBC (assess for anemia or polycythemia), comprehensive metabolic panel (evaluate kidney function and calcium levels), and urinalysis with microscopy. Elevated alkaline phosphatase may indicate bone metastasis requiring immediate bone scan.

Key Points

  • Biopsy rarely performed due to risk of tumor seeding
  • MRI used when CT contraindicated or for surgical planning
  • Chest X-ray/CT essential - lungs are most common metastatic site

Treatment and Nursing Management

Surgical Interventions

  1. Radical nephrectomy is the treatment of choice for localized disease, involving removal of kidney, adrenal gland, surrounding fascia, and regional lymph nodes.
  2. Partial nephrectomy (nephron-sparing surgery) is preferred for small tumors (<4 cm) or patients with solitary kidney to preserve renal function.
  3. Laparoscopic approaches offer reduced morbidity, shorter hospital stays, and faster recovery compared to open surgery.

Post-Nephrectomy Nursing Care

Immediate Post-Op Priorities:

  • Monitor for hemorrhage - assess surgical site, vital signs, and urine output
  • Maintain adequate fluid balance while avoiding fluid overload
  • Position patient to promote drainage and prevent pneumonia
  • Assess remaining kidney function through creatinine and BUN levels

Systemic Therapies

  • Targeted therapy agents like sunitinib and pazopanib inhibit tumor angiogenesis and are first-line treatments for metastatic disease. Monitor for hypertension, diarrhea, and hand-foot syndrome as common side effects.
  • Immunotherapy with checkpoint inhibitors (nivolumab, pembrolizumab) has shown promising results in advanced RCC. Monitor for immune-related adverse events including pneumonitis, colitis, and endocrinopathies.

Key Points

  • Traditional chemotherapy and radiation therapy are largely ineffective for RCC
  • Cytoreductive nephrectomy may be performed before systemic therapy
  • Regular follow-up imaging essential due to high recurrence risk

Commonly Confused Points

Kidney Tumor vs. Other Renal Conditions

Condition Key Distinguishing Features Diagnostic Approach
Renal Cell Carcinoma • Painless hematuria
• Solid mass on imaging
• Systemic symptoms		 • CT with contrast
• No biopsy needed
Renal Cyst • Usually asymptomatic
• Fluid-filled on imaging
• No enhancement with contrast		 • Ultrasound sufficient
• Bosniak classification
Pyelonephritis • Fever, flank pain
• Dysuria, frequency
• Acute onset		 • Urinalysis and culture
• Clinical presentation

Memory Aid: RCC Treatment Sequence

"FIRST CUT, THEN TARGET"
F - Find and stage the tumor
I - Immediate surgical evaluation
R - Radical or partial nephrectomy
S - Surveillance for recurrence
T - Targeted therapy if metastatic

Study Tips and Quick Checks

High-Yield NCLEX Points

  • Remember the classic triad is rare - most patients present with isolated hematuria or are asymptomatic. Focus on the significance of painless hematuria in older adults requiring immediate evaluation.
  • Post-nephrectomy patients need lifelong monitoring of remaining kidney function and should avoid nephrotoxic medications including NSAIDs and certain antibiotics.

Common Pitfalls to Avoid

  • Don't assume hematuria is always from UTI in older adults
  • Don't forget to assess for paraneoplastic syndromes
  • Don't overlook the need for long-term follow-up care

Quick Check Questions

□ Can you identify the most common presenting symptom of RCC?

□ Do you know why biopsy is rarely performed for kidney tumors?

□ Can you list three paraneoplastic syndromes associated with RCC?

□ Do you understand the difference between radical and partial nephrectomy?

Remember: You're preparing to save lives and provide compassionate care. Every concept you master brings you closer to becoming the nurse your future patients need. Stay focused, stay positive, and trust in your preparation! 🌟

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.